Improving Tumor Control in Mesothelioma with Combined Treatments
Author Information
Author(s): Kirschner Michaela B. PhD, Meerang Mayura PhD, Orlowski Vanessa, Furrer Katarzyna MD, Tschanz Fabienne PhD, Grgic Ivo PhD, Cecconi Virginia PhD, van den Broek Maries PhD, Guckenberger Matthias MD, Pruschy Martin MD, Lauk Olivia MD, Opitz Isabelle MD
Primary Institution: University Hospital Zurich, Zurich, Switzerland
Hypothesis
Can intracavitary cisplatin-fibrin combined with irradiation improve tumor control in pleural mesothelioma?
Conclusion
The combination of intracavitary cisplatin-fibrin and irradiation significantly delays tumor growth compared to single treatments in a rat model of pleural mesothelioma.
Supporting Evidence
- The combination treatment resulted in significantly smaller tumors compared to single treatments.
- Short-term side effects were observed but were manageable.
- 10 Gy irradiation did not impact tumor growth compared to cis-fib alone.
Takeaway
This study shows that using a special treatment with cisplatin and radiation together helps slow down the growth of tumors in rats with a type of lung cancer.
Methodology
Male F344 rats were randomized into five treatment groups and monitored for tumor growth using bioluminescent imaging after receiving various treatments.
Potential Biases
Potential bias in treatment allocation and monitoring due to the nature of animal studies.
Limitations
The study used a single high dose of irradiation, which may not reflect typical clinical practice, and the model may not fully replicate human disease.
Participant Demographics
Male Fischer 344 rats, 10 weeks old.
Statistical Information
P-Value
0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website